课题基金 / 基金详情

Regulation of Vascular Inflammation

Regulation of Vascular Inflammation
血管炎症的调节
批准号:
7054712
负责人:
CHARLES J LOWENSTEIN
金额:
$31.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2008-03-31

项目摘要

项目成果

CHARLES J LOWENSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis is an inflammatory disease. Clinical studies show that elevated serum markers of inflammation predict an increased risk for atherosclerosis. Animal studies show that inflammatory mediators play a role in atherogenesis. Although pro-inflammatory pathways have been shown to increase atherosclerosis, the protective roles of anti-inflammatory pathways are less well studied. We and others have previously shown that nitric oxide (NO) inhibits vascular diseases. ApoE null mice that also lack the endothelial nitric oxide synthase (eNOS, or NOS3) gene have more severe atherosclerosis than ApoE mice that express NOS3. In humans, endothelial dysfunction (characterized by an inability to produce NO) is associated with coronary artery disease (CAD). Thus, NO may protect the vasculature from atherosclerosis. The molecular mechanisms by which NO inhibits atherosclerosis are unknown. However, we and others recently discovered that NOS decreases inflammation in transplant arteriosclerosis. In particular, we found that the inducible nitric oxide synthase (iNOS, or NOS2) inhibits the release of WeibeI-Palade bodies from endothelial cells in donor hearts. Since WeibeI-Palade bodies contain inflammatory and thrombotic mediators, inhibition of WeibeI-Palade body release may explain part of the anti-inflammatory effects of NO in transplant vasculopathy and other inflammatory vascular diseases, including atherosclerosis. We hypothesize that NO derived from NOS inhibits vascular inflammation, in part by inhibiting WeibeI-Palade body exocytosis. We now propose to explore the molecular mechanisms by which NO inhibits WeibeI-Palade body release. Preliminary Data show that NO blocks WeibeI-Palade body release from cultured endothelial cells. We will begin by determining the mechanisms by which WeibeI-Palade bodies are normally released. We will next define the molecules of the exocytosis machinery that are targets of NO. Finally, we will examine the role of reactive oxygen species in regulating WeibeI-Palade body exocytosis. These studies will characterize novel molecular mechanisms by which radicals regulate vascular inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
  • 批准号:
    10418628
  • 项目类别:
  • 资助金额:
    $62.68万
  • 财政年份:
    2020
  • 负责人:
    CHARLES J LOWENSTEIN
  • 依托单位:
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
  • 批准号:
    10164668
  • 项目类别:
  • 资助金额:
    $67.29万
  • 财政年份:
    2020
  • 负责人:
    CHARLES J LOWENSTEIN
  • 依托单位:
Population genomic variation, functional biology, and the risk of venous thrombosis
  • 批准号:
    9750789
  • 项目类别:
  • 资助金额:
    $71.08万
  • 财政年份:
    2017
  • 负责人:
    CHARLES J LOWENSTEIN
  • 依托单位:
VAMP8 regulates endothelial exocytosis and microvascular obstruction
  • 批准号:
    8903561
  • 项目类别:
  • 资助金额:
    $38.38万
  • 财政年份:
    2014
  • 负责人:
    CHARLES J LOWENSTEIN
  • 依托单位:
国内基金
海外基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
  • 批准号:
    91957111
  • 项目类别:
    重大研究计划
  • 资助金额:
    80.0万元
  • 批准年份:
    2019
  • 负责人:
    李佩盈
  • 依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 项目类别:
    面上项目
  • 资助金额:
    14.0万元
  • 批准年份:
    2011
  • 负责人:
    刘梅林
  • 依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
  • 批准号:
    81070247
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    秦树存
  • 依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
  • 批准号:
    81000086
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    江立生
  • 依托单位: